CHD4 and medulloblastoma: Moreover, the large number of somatic mutations in CHD4 seen in different cancer types (carcinomas, gliomas, medulloblastoma, hematopoietic, and lymphoid) in different tissues (gynecological, nervous system, lymphoid organs, intestine, kidney, lung, etc.) (31–38) make this epigenetic regulator worthy of attention.